Andreas Obermair
Source: https://about.uq.edu.au/experts/5973 Parent: https://about.uq.edu.au/experts/1976
Professor
Andreas Obermair
Email: : a.obermair@uq.edu.au
Phone: : +61 7 334 66044
Positions
NHMRC Leadership Fellow : UQ Centre for Clinical Research : Faculty of Health, Medicine and Behavioural Sciences
Affiliate of Centre for Extracellular Vesicle Nanomedicine : Centre for Extracellular Vesicle Nanomedicine : Faculty of Health, Medicine and Behavioural Sciences
Overview
Background
Professor Obermair is the Director of Queensland Centre for Gynaecological Cancer Research (QCGC Research). He is a Professor of Gynaecological Oncology since 2007, a Senior Medical Officer at Royal Brisbane & Women’s Hospital and a Visiting Medical Officer at St Andrews War Memorial Hospital and Buderim Private Hospital. He holds an Honorary title of Professor at UQ since 2006.
Professor Obermair is an internationally recognised leader in gynaecological oncology research and treatment and has lead the research team at QCGC Research since establishing it in 2003.
Read more Read less
Availability
Professor Andreas Obermair is: : Available for supervision
Fields of research
Biological Sciences Biomedical and Clinical Sciences Health Sciences Medical microbiology Oncology and carcinogenesis
Qualifications
- Doctoral Diploma of Medicine, International University Vienna
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Royal Australian and New Zealand College of Obstetricians and Gynaecologists
Research interests
-
Clinical Trials
Decisions on cancer management ideally are based on the results of high-level evidence, obtained through clinical trials whenever possible. As a principle, a new (proposed better) intervention should be compared to the current standard treatment before being made available generally. Outside a clinical trial new treatments should not become available until evidence has become available to demonstrate superiority over the current standard treatment. Retrospective studies harbour the risk that biases influenced outcomes. At QCGC Research we engage in phase 2 and 3 clinical trials. In large phase trials, patients are allocated randomly to one of two or more interventions in order to minimise the risk of bias. Generally, patients treated within clinical trials have a better outcome compared to patients who are not treated in clinical trials. As the Director of Research Gynaecological Oncology I am currently involved in developing and managing clinical trials in gynaecological cancers.
Read more Read less - #### Translational Research
The focus of QCGC Research's translational research program is the application of new technology (molecular, biochemical, imaging and surgical) to prevention, detection and therapy for gynaecological cancers.
Read more Read less - #### Quality of Life Research
Cancer specialists are aware that not only the survival time but also the quality of life is a key factor in cancer treatment. This is especially important when two treatments are equally effective but cause different side-effects. My Quality-of-Life research focuses on ovarian, endometrial, cervical and vulval cancer. I wish to provide the best, most effective and modern treatment to my patients with least possible detriments to quality of life.
Read more Read less - #### Minimally Invasive Surgery
In Australia, around 30,000 hysterectomies are conducted annually to treat uterine cancer and various benign gynaecological conditions. While open abdominal surgery may be necessary in around 10% of cases, evidence shows that less-invasive approaches, such as total laparoscopic hysterectomy (TLH) can achieve better outcomes for women at a lower overall cost to the health system. Yet, in Queensland, four of ten hysterectomies are still conducted by open abdominal surgery. Our own research has shown that many Australian surgeons are keen to adopt new techniques such as TLH, but that the lack of systematic training and mentoring opportunities is the main impediment to practice-change. Together with gynaecological surgical teams at hospitals and industry support we developed a prototype for system-level transformative practice change in gynaecological surgery.
Read more Read less
Research impacts
Professor Obermair is an innovative and skilled gynaecologic oncologist, surgical teacher and consumer advocate. His international leadership and research impact was acknowledged in 2020 by the Australian community, when he was awarded an NHMRC Investigator Fellowship Level 2 (2021-25). The national impact of his research was recognised in 2017, when he was awarded Cancer Australia’s Jeannie Ferris Recognition Award (2017), for outstanding achievements in clinical practice and research. He is deeply engaged in consumer involvement and co-founded and serves on the Board of the Cherish Foundation, a consumer-focussed organisation that funds clinical research in better treatments for women with gynaecological cancers.
Read more Read less
Works
Search Professor Andreas Obermair’s works on UQ eSpace
All (375) Journal Article (329) Other Outputs (2) Conference Publication (43) Book Chapter (1)
2026
Journal Article
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial
Virili, Florencia, Obermair, Andreas, Sanjida, Saira, Nicklin, James L., Garrett, Andrea, Land, Russell, Tang, Amy, Campbell, Louise, Gebski, Val and Thomas, Paul (2026). Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial. International Journal of Gynecologic Cancer, 36 (1) 101854, 1-9. doi: 10.1136/ijgc-2024-005633
2026
Journal Article
Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement
Salani, Ritu, Atallah, David, Fader, Amanda N., Frimer, Marina, Obermair, Andreas, Pareja, Rene and Huang, Marilyn (2026). Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement. Gynecologic Oncology, 204, 109-117. doi: 10.1016/j.ygyno.2025.11.014
2025
Journal Article
Efficacy of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: An Updated Systematic Review and Meta-analysis
King, Abigail, Harris, William, Campbell, Zara, Hazelton, Annabelle and Obermair, Andreas (2025). Efficacy of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: An Updated Systematic Review and Meta-analysis. International Journal of Gynecological Cancer, 36 (2) 102865, 102865. doi: 10.1016/j.ijgc.2025.102865
2025
Journal Article
Extracellular vesicles as biomarkers for endometrial cancer – a systematic review
Baxter, Eva, Nair, Soumyalekshmi, West, Zoe, Salomon, Carlos and Obermair, Andreas (2025). Extracellular vesicles as biomarkers for endometrial cancer – a systematic review. Translational Oncology, 62 102543, 1-10. doi: 10.1016/j.tranon.2025.102543
Extracellular vesicles as biomarkers for endometrial cancer – a systematic review
2025
Journal Article
Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial
Baxter, Eva, Robledo, Kristy P., Cummings, Margaret, Alizart, Michelle, Smith, Deborah and Obermair, Andreas (2025). Central pathology review of endometrial hyperplasia and adenocarcinoma before and after treatment with the levonorgestrel intrauterine device–results from the feMMe phase 2 randomized clinical trial. American Journal of Surgical Pathology, 50 (2), 259-266. doi: 10.1097/pas.0000000000002492
2025
Journal Article
LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL
Baxter, Eva, Robledo, Kristy, Gebski, Val, Chen, Chen, Garrett, Andrea, Tang, Amy, Land, Russell, Nicklin, James, Chetty, Naven, Janda, Monika and Obermair, Andreas (2025). LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL. International Journal of Gynecological Cancer, 35 (11) 102239, 102239. doi: 10.1016/j.ijgc.2025.102239
2025
Journal Article
Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial
Al Ramadhani, Ruqaiya, Janda, Monika, Playdon, Mary and Obermair, Andreas (2025). Diet and lifestyle quality in Australian women with endometrial cancer at diagnosis – insights from the FeMMe trial. Current Developments in Nutrition, 9 (12) 107572, 1-10. doi: 10.1016/j.cdnut.2025.107572
2025
Journal Article
CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer
Cohen, P.A., Obermair, A., Gebski, V., King, M.T., Butow, P., Campbell, R., Bilic, S., Brand, A., Codde, J., Goh, J.C.H., Ives, A., Kiberu, A.D., Lawson, W., Mellon, A., McNally, O., Meniawy, T., Mileshkin, L., Morton, R., Webb, P. and Friedlander, M.L. (2025). CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer. Annals of Oncology, 36, S1650-S1539. doi: 10.1016/j.annonc.2025.08.1166
2025
Journal Article
Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium
Nasioudis, Dimitrios, Wohlmuth, Christoph, Albright, Benjamin, McDonald, Megan, Wallace, Sumer, Glickman, Ariel, Do, Anthony, Mantia-Smaldone, Gina, Grassi, Tommaso, Fleming, Elaine, Tsibulak, Irina, Reis, Ricardo Dos, Cucinella, Giuseppe, Heredia, Fernando, Pereira, Augusto, Bogani, Giorgio, Buckingham, Lindsey, Baiocchi, Glauco, Mills, Kathryn, AlHilli, Mariam, Obermair, Andreas, Covens, Allan, Mariani, Andrea, Plante, Marie and Giuntoli, Robert (2025). Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium. Gynecologic Oncology, 200, 18-19. doi: 10.1016/j.ygyno.2025.03.075
2025
Conference Publication
“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations
Campbell, Rachel, Jeon, Megan, Friedlander, Michael, King, Madeleine T., Obermair, Andreas, Bilic, Sanela, Brand, Alison, Butow, Phyllis, Codde, Jim, Gebski, Val, Goh, Jeffrey C., Ives, Angela, Lawson, Wanda, McNally, Orla, Meniawy, Tarek, Mileshkin, Linda R., Morton, Rachael L., Webb, Penelope M., Yates, Patsy and Cohen, Paul Andrew (2025). “The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations. 2025 ASCO Annual Meeting, Chicago, IL United States, 30 May - 3 June 2025. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2025.43.16_suppl.12099
2025
Journal Article
Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery
West, Simon, Jayasinghe, Dilki, Davie, Stacey and Obermair, Andreas (2025). Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery. International Journal of Gynecological Cancer, 35 (8) 101993, 101993. doi: 10.1016/j.ijgc.2025.101993
2025
Other Outputs
The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery
Obermair, Helena, Dissanayake, D. M. Sadrushi L. and Obermair, Andreas (2025). The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery. Brisbane, QLD, Australia: The University of Queensland. doi: 10.14264/3ddf262
The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery
2025
Journal Article
Subjective Assessment of Adnexal Masses Using Various Ultrasonographic Diagnostic Models: An Analysis of Interobserver Variability
Rizzuto, Ivana, Rezai, Shohreh, Lane, Annah, Prior, Marita, Robledo, Kristy P. and Obermair, Andreas (2025). Subjective Assessment of Adnexal Masses Using Various Ultrasonographic Diagnostic Models: An Analysis of Interobserver Variability. Australian & New Zealand Journal of Obstetrics & Gynaecology, 65 (6), 792-799. doi: 10.1111/ajo.70036
2025
Journal Article
Patterns of Care for Vulval Cancer Treatment: The Queensland Experience
Davie, S., Obermair, A. and West, Ze (2025). Patterns of Care for Vulval Cancer Treatment: The Queensland Experience. International Journal of Gynecological Cancer, 35 (7) 101956, 101956-7. doi: 10.1016/j.ijgc.2025.101956
Patterns of Care for Vulval Cancer Treatment: The Queensland Experience
2025
Journal Article
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers
Tuesley, Karen M., Spilsbury, Katrina, Pearson, Sallie-Anne, Donovan, Peter, Obermair, Andreas, Coory, Michael D., Ali, Sitwat, Pandeya, Nirmala, Stewart, Louise, Jordan, Susan J. and Webb, Penelope M. (2025). Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers. JNCI: Journal of the National Cancer Institute, 117 (5) djae282, 1046-1055. doi: 10.1093/jnci/djae282
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers
2025
Journal Article
A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma
Obermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer, 35 (4) 101644, 1-9. doi: 10.1016/j.ijgc.2025.101644
2025
Journal Article
Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer
Gersekowski, Kate, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2025). Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer. Journal of Epidemiology and Community Health, 79 (9), 684-690. doi: 10.1136/jech-2024-222687
Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer
2025
Journal Article
What is the true prognosis of T1a cervical cancer?
Ng, Zheng Yuan, Manchanda, Ranjit, Lopez, Aldo, Obermair, Andreas, Dostalek, Lukas, Pareja, Rene, Van Lonkhuijzen, Luc R.c.w., Falconer, Henrik, Ortiz, David Isla, Fagotti, Anna, Ramirez, Pedro T., Landoni, Fabio, Weinberger, Vít, Laky, Rene, Kim, Sarah K., Klát, Jaroslav, Kocián, Roman, Nemejcova, Kristyna and Cibula, David (2025). What is the true prognosis of T1a cervical cancer?. International Journal of Gynecological Cancer, 35 (2 s1) 100442, 100442. doi: 10.1016/j.ijgc.2024.100442
What is the true prognosis of T1a cervical cancer?
2025
Journal Article
Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644))
Obermair, Andreas, Gebski, Val, Goh, Jeffrey, Kuchel, Anna, Brand, Alison, Mak, Blossom, McNally, Orla, Baxter, Eva, Jobling, Thomas and Mileshkin, Linda (2025). Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644] (International Journal of Gynecological Cancer (2025) 35(4), (S1048891X25001677), (10.1016/j.ijgc.2025.101644)). International Journal of Gynecological Cancer, 35 (9) 101961, 101961. doi: 10.1016/j.ijgc.2025.101961
2025
Journal Article
The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims
Collings, Rachel, Potter, Christian, Gebski, Val, Janda, Monika and Obermair, Andreas (2025). The impact of surgical complications on obstetricians’ and gynecologists' wellbeing and coping mechanisms as second victims. American Journal of Obstetrics and Gynecology, 232 (1), 104.e1-104.e12. doi: 10.1016/j.ajog.2024.07.043
Funding
Current funding
- 2026 - 2030
Towards evidence-supported precision surgery for gynaecological cancer
NHMRC Investigator Grants
Open grant - 2025 - 2028
The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
Cherish Women's Cancer Foundation
Open grant - 2025 - 2030
Centre of Research Excellence to Improve the QuALIty of SurVival in Gynaecological Cancer PatiEnts (ALIVE WELL)
NHMRC Centres of Research Excellence
Open grant - 2025 - 2026
The Australian National Vulvar Cancer (ANVU) trial: A Phase II clinical trial of groin ultrasound surveillance to de-escalate surgical intervention in vulvar cancer
Cherish Women's Cancer Foundation
Open grant - 2024 - 2029
The EARLY study: Evaluating the Specificity and feasibility of the EARLY Test for Ovarian Cancer Detection
NHMRC Partnership Projects
Open grant - 2024 - 2027
Moving without fear when living with stoma: A consumer-led physical activity study (MRFF CLR Grant administered by Griffith University)
Griffith University
Open grant - 2024 - 2029
Salpingectomy with delayed oophorectomy to prevent ovarian cancer (TUBA WISP II) (MRFF ICTC Grant led by University of Melbourne)
University of Melbourne
Open grant - 2024 - 2027
EN.10 - A Phase II study of adjuvant therapy in pole-mutated and p53-wildtype/NSWP early stage endometrial cancer (RAINBO BLUE & TAPER)
Australia New Zealand Gynaecological Oncology Group
Open grant - 2024 - 2028
ENDO3:A Phase III Randomised Controlled Clinical Trial Comparing Disease-Free Survival of Patients with or without Lymph Node Dissection in clinical stage I Endometrial Cancer (ANZGOGtrial #1911/2020)
NHMRC Clinical Trials and Cohort Studies Grants
Open grant - 2023 - 2028
Vulvar Cancer Feasibility Study: Establishing a novel pathway to best-practice treatment in vulvar cancer
Research Donation Generic
Open grant - 2022 - 2026
A non-surgical alternative to hysterectomy for the treatment of endometrial cancer
NHMRC Partnership Projects
Open grant - 2010 - 2026
QCOG (Data Manager Grant)
Cancer Council Queensland
View all 12 current funded projects View less
Past funding
- 2024
Moving without fear when living with stoma: A consumer-led physical activity study
NHMRC MRFF PPHR - Consumer Led Research
Open grant - 2024 - 2025
Queensland Centre for Gynaecological Cancer's NODE Study
Gynaecological Cancer Research, Education and Development Society Limited Research Grant
Open grant - 2024
Improving quality of life for vulvar cancer patients through non-invasive interventions
Metro North Hospital and Health Service
Open grant - 2021 - 2024
MOST (Measure of Ovarian Symptoms and Treatment concerns)
St John of God Healthcare Inc
Open grant - 2021 - 2025
Creating treatment options for endometrial cancer through high-level clinical trials
NHMRC Investigator Grants
Open grant - 2020 - 2022
A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial)
Cherish Women's Cancer Foundation
Open grant - 2020 - 2024
A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (MRFF EPCDR administered by Griffith).
Griffith University
Open grant - 2020 - 2023
Implementing non-surgical options for endometrial cancer treatment into clinical practice
ICON Cancer Care
Open grant - 2020 - 2021
A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
Metro North Hospital and Health Service
Open grant - 2019 - 2020
feMMe Long Term Follow-Up study
ASGO Research Grants
Open grant - 2019 - 2020
A Phase III Randomised Clinical Trial Comparing Sentinel Node Biopsy with No Retroperitoneal Node Dissection in Early-Stage Endometrial Cancer (ENDO-3)
Gynaecological Cancer Research, Education and Development Society Limited Research Grant
Open grant - 2017 - 2020
The Implementation of MinimAlly INvasivE hysterectomy (IMAGINE) trial
NHMRC Partnership Projects
Open grant - 2017 - 2018
Transforming surgical practice through innovation IMAGINE
Metro North Hospital and Health Service
Open grant - 2017 - 2021
The ECHO trial: Exercise during CHemotherapy for Ovarian cancer (World Cancer Research Fund International grant administered by QUT)
Queensland University of Technology
Open grant - 2017 - 2021
The Ovarian Cancer Prognosis and Lifestyle (OPAL) Study: Long-term outcomes (NHMRC Project Grant administered by QIMR)
Queensland Institute of Medical Research
Open grant - 2016 - 2018
Long-term follow-up of the Laparoscopic Approach to Carcinoma of the Endometrium (LACE) Trial - survival outcomes
Cancer Australia
Open grant - 2016
QCOG 2016
Cancer Council Queensland
Open grant - 2015 - 2019
Cherish women's cancer foundation research fellow funding
Cherish Women's Cancer Foundation
Open grant - 2015 - 2022
ECHO trial: Exercise during Chemotherapy for Ovarian cancer (Cancer Australia grant administered by The University of Sydney)
University of Sydney
Open grant - 2015 - 2018
The fEMMe trial
Cancer Australia
Open grant - 2015 - 2016
In Memory of Denise Marcella Collins
Research Donation Generic
Open grant - 2015 - 2016
Impact of gated PET/CT on the diagnosis of distant metastases of advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer
Royal Brisbane and Women's Hospital
Open grant - 2015 - 2019
Selective targeting of adjuvant therapy for endometrial cancer: the STATEC trial (NHMRC Project Grant administered by University of Sydney)
University of Sydney
Open grant - 2014 - 2015
A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
Royal Brisbane and Women's Hospital Foundation
Open grant - 2014 - 2015
Barriers of the uptake of laparoscopic hysterectomy
Australian Centre for Health Services Innovation
Open grant - 2014 - 2015
A Phase II Randomised Clinical Trial of Mirena® ± Metformin ± Weight Loss Intervention in Patients with Early Stage Cancer of the Endometrium
Australia New Zealand Gynaecological Oncology Group
Open grant - 2014 - 2015
Prophylactic surgery and breast cancer
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2013 - 2020
ACRF Molecular Oncology Translational Imaging Facility (MOTIF)
Australian Cancer Research Foundation
Open grant - 2013 - 2016
Mirena ±Weight Loss to treat early Endometrial Cancer (MAxWEL Trial - Cancer Australia grant administered by Queensland University of Technology)
Queensland University of Technology
Open grant - 2013
A phase II randomised clinical trial of mirena +/- metformin in patients with early stage cancer of the endometrium
Royal Brisbane and Women's Hospital
Open grant - 2013
QCOG 2013 (Data Manager Grants)
Cancer Council Queensland
Open grant - 2012 - 2023
In Memory of Jan Sanders and other philanthropic donations
Research Donation Generic
Open grant - 2012 - 2013
LEGS follow-up: Lymphoedema Evaluation following Gynaecology Cancer Study
Queensland University of Technology
Open grant - 2012 - 2013
The effect of prophylactic, risk-reducing gynaecological surgery on survival among patients with a history of breast cancer
Royal Brisbane and Women's Hospital
Open grant - 2011 - 2012
HE 4 Collaborative Study
Abbott Australasia Pty Ltd
Open grant - 2011
LEGS:Lymphoedema Evaluation in Gynaecological Cancer Study
Royal Brisbane and Women's Hospital
Open grant - 2011 - 2012
Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
Wesley Merdical Research
Open grant - 2010 - 2023
A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal radical hysterectomy in patients with early stage cervical cancer (Clinical Trial Agreement)
University of Texas M.D. Anderson Cancer Centre
Open grant - 2010 - 2013
Laparoscopic Approach to Carcinoma of the Endometrium. An international multicentre randomised Phase 3 clinical trial
Cancer Australia
Open grant - 2010 - 2013
Postoperative Enteral Nutrition in Patients with Advanced Epithelial Ovarian Cancer
Cancer Australia
Open grant - 2009 - 2011
National Gynaecological Cancers Service Delivery and Resources Framework
Cancer Australia
Open grant - 2009 - 2012
Mayne Bequest Fund Research Support Award: Research & development into better standard of care for women experiencing gynaecological cancer
Mayne Bequest Fund
Open grant - 2009 - 2012
A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Patients with Early Stage Cervical Cancer
University of Texas M.D. Anderson Cancer Centre
Open grant - 2009 - 2010
Cancer Clinical Trial Data Management Grant 2009
Cancer Council Queensland
Open grant - 2009 - 2010
Post-operative enteral nutrition among patients with ovarian cancer
Gallipoli Research Foundation
Open grant - 2009
Prognostic value of preoperative CA125 in ovarian tumours of low malignant potential
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2009 - 2010
Prospective evaluation of lymphoedema among patients with gynaecological cancer
Gallipoli Research Foundation
Open grant - 2008 - 2011
Prospective evaluation of lymphoedema among patients with gynaecological cancer
Wesley Merdical Research
Open grant - 2008 - 2011
Prospective evaluation of lymphoedema among patients with gynaecological cancer
Cancer Australia
Open grant - 2008 - 2009
LACE - Laparoscopic Approach to Carcinoma of the Endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2008
Cancer Clinical Trial Data Management grant 2008
Queensland Cancer Fund
Open grant - 2008
Laparoscopic approach to cervical carcinoma -a phase III randomised clinical trial of laparoscopic radical hysterectomy versus abdominal radical hysterectomy in patients w/ early stage cervical cancer
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2007 - 2009
Total Laparoscopic hysterectomy for Endometrial Cancer
Queensland Health Smart Health Research Grant
Open grant - 2007
Cancer Clinical Trial Data Manager, QLD Centre for Gynaecological cancer - 2007
Queensland Cancer Fund
Open grant - 2007
LACE- Laparoscopic approach to carcinoma of the endometrium - An international multicentre randomised phase 3 clinical trial - Top-Up funding
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2007 - 2009
Total Laparoscopic Hysterectomy (TLH) vs. Total Abdominal Hysterectomy (TAH) for the Treatment of Endometrial Cancer
NHMRC Project Grant
Open grant - 2006
Cancer Clinical Trial Data Manager at the QLD Centre for Gynaecological Cancer
Queensland Cancer Fund
Open grant - 2006
LACE - Laparoscopic approach to carinoma of the endometrium - An International Multicentre Randomised Phase 3 Clinical Trial
Queensland Cancer Fund
Open grant - 2006 - 2007
Total laparoscopic hysterectomy (TLH) vs Total Abdominal Hysterectomy (TAH) for the treatment of endometrial cancer
Queensland Cancer Fund
Open grant - 2005 - 2006
Clinical Trial Data Manager
Queensland Cancer Fund
Open grant - 2005 - 2006
Start-up Grant
Royal Brisbane & Women's Hospital Research Foundation
Open grant - 2004 - 2007
Gynaecological Cancer Society Research Grants
Gynaecological Cancer Society
Open grant - 2004
Mismatch repair gene defects in endometrial cancer patients less than 50 years of age
Royal Brisbane & Women's Hospital Research Foundation
View all 63 past funded projects View less
Supervision
Availability
Professor Andreas Obermair is: : Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Available projects
-
Improving Quality of Survival for Women with Gynaecological Cancer
-
Focus on improving quality of life, health & function during & after gynaecological cancer treatment, with a focus on biomarker research, implementation research and cancer survivorship.
Read more Read less
Supervision history
Current supervision
- Doctor Philosophy
##### Advanced methods for biomarker informed endometrial cancer
Principal Advisor
Other advisors: Dr Eva Baxter, Dr Zoe West, Professor Andrew Martin - Master Philosophy
##### Patterns of care in endometrial cancer management in Queensland: a retrospective analysis.
Principal Advisor
Other advisors: Dr Eva Baxter
Completed supervision
- 2014
Doctor Philosophy
Principal Advisor
Other advisors: Honorary Professor Amanda Spurdle, Associate Professor Lisa Fitzgerald - 2008
Doctor Philosophy
##### Nutritional status of patients with gynaecological cancer -
Joint Principal Advisor
Other advisors: Emeritus Professor Geoffrey Cleghorn - 2026
Doctor Philosophy
Associate Advisor
Other advisors: Professor Monika Janda - 2009
Doctor Philosophy
##### Biology of CA125 in ovarian cancer biology
Associate Advisor
Other advisors: Honorary Professor Michael McGuckin
Media
Enquiries
For media enquiries about Professor Andreas Obermair's areas of expertise, story ideas and help finding experts, contact our Media team:
External profiles
Personal links
Social media
Log in to Academic Portal to update your profile